NCT01623076Active, not recruiting
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Collaboration on Neuroimmunology: Question, Understand, Educate, Restore - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Source: ClinicalTrials.gov · Last updated 6 Jan 2026
Brief summary (registry, in English)
This study seeks to determine the biologic causes of inflammation in patients with Transverse Myelitis (TM) Neuromyelitis Optica Spectrum Disorder (NMOSD) and related conditions. While patients will be treated according to decisions with their treating physician, this study will collect data and samples from patients prospectively to gain a better understanding of the disease. We are seeking to understand why some patients respond to medications, while others do not. We also seek to understand what happens biologically, preceding relapses. Gathering these data and samples will allow researchers to identify new ways of diagnosing and treating these diseases. Data and samples will be shared with researchers around the world to support collaborative efforts to treat these conditions.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 15 Jun 2012
- Start date
- Jun 2012
- Primary completion date
- Jun 2030
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Neuromyelitis optica (NMOSD)
- NCT number
- NCT01623076
What you commit to
- Study type: Observational
- Planned participants: 150
- From Jun 2012 to the primary completion date, Jun 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient has known HIV or hepatitis C infection
Other
- Unable to maintain scheduled visits
Who the study is looking for
- Age 6 years or greater
- Male or Female
- Patient or Parent (in the case of a minor) able to give informed consent
- For patients 10 to 17, patient able to assent
- Patient diagnosed with NMO, NMOSD, TM or ON
Age in the registry: 6 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.